[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353880-105":59,"doc-detail-353880-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tcf7l2depdc1-axis-contributes-to-tumor-progression-by-promoting-cell-proliferation-aerobic-glycolysis-and-immunosuppression-in-pancreatic-cancer","TCF7L2/DEPDC1 axis contributes to tumor progression by promoting cell proliferation, aerobic glycolysis, and immunosuppression in pancreatic cancer","","Pancreatic ductal adenocarcinoma (PDAC) shows a persistently poor prognosis, and the molecular basis for disease progression remains insufficiently defined. DEP domain containing 1 (DEPDC1) dysregulation is implicated across multiple cancers, yet its function in PDAC is unclear. This study demonstrates DEPDC1 overexpression in PDAC tissues versus adjacent normal tissues, with expression correlating to worse outcomes. TCF7L2 increases DEPDC1 by promoter binding, and the resulting TCF7L2/DEPDC1 axis drives proliferation, invasion, glycolysis reprogramming, immune escape, and tumor progression, supporting a therapeutic strategy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tcf7l2depdc1-axis-contributes-to-tumor-progression-by-promoting-cell-proliferation-aerobic-glycolysis-and-immunosuppression-in-pancreatic-cancer/353880/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tcf7l2depdc1-axis-contributes-to-tumor-progression-by-promoting-cell-proliferation-aerobic-glycolysis-and-immunosuppression-in-pancreatic-cancer/353880.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of the study on TCF7L2/DEPDC1 in PDAC?","Question",{"text":112,"@type":113},"To determine whether the TCF7L2/DEPDC1 axis contributes to pancreatic cancer progression and to clarify its effects on proliferation, aerobic glycolysis, and immunosuppression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers assess the relationship between DEPDC1 expression and PDAC prognosis?",{"text":117,"@type":113},"They compared DEPDC1 expression in PDAC tissues and adjacent normal tissues and then evaluated how expression levels correlated with patient outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism did the study propose linking TCF7L2 to DEPDC1 and tumor progression?",{"text":121,"@type":113},"TCF7L2 up-regulated DEPDC1 by binding specifically to DEPDC1 promoter sequences, which then promoted proliferation and invasion via glycolysis and helped form an immunosuppressive tumor microenvironment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353880,1791171448,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Clinical and Experimental Medicine (2026) 26:183  \n[https://doi.org/10.1007/s10238-026-02109-3](https://doi.org/10.1007/s10238-026-02109-3)  \nCORRESPONDENCE  \nTCF7L2/DEPDC1 axis contributes to tumor progression by promoting cell proliferation, aerobic glycolysis, and immunosuppression in pancreatic cancer  \nYesiboliTasiheng1 · Jiayideng Kenjiabieke2 · NuerzhatiTasiheng3 · Kawushaer Adilijiang4 · He Cheng5,6,7,8  \nReceived: 11 December 2025 / Accepted: 14 February 2026 © The Author(s) 2026  \nAbstract  \nThe prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) still remains poor and the exact molecular mechanisms still unclear. Dysregulation of DEP domain containing 1 (DEPDC1) has been implicated in the pathogenesis of a variety of cancers. However, the role of DEPDC1 in PDAC is poorly understood. Here in this study, we identified that DEPDC1 was high-expressed in PDAC tissues compared with the adjacent normal pancreatic tissues, and its expression level was correlated with poor prognosis of PDAC. We also found that TCF7L2 up-regulated DEPDC1 expression by binding to its promoter sequence specifically. Further bioinfromatic and functional analysis demonstrated that the TCF7L2/ DEPDC1 axis can promote tumor cell proliferation and invasion by upregulating glycolysis. Glycolysis reprogramming influences the activation and function of immune cells, ultimately leading to immune escape and cancer progression. Inconsistent with this, our results showed that the TCF7L2/DEPDC1 axis could form an immunosuppressive tumor microenvironment via promoting tumor glycolysis. Our findings revealed the critical role of TCF7L2/DEPDC1 axis in the carcinogenesis and development of PDAC, which provided a promising therapeutic strategy to improve the prognosis of PDAC patients.  \nKeywords Pancreatic ductal adenocarcinoma · DEPDC1 · TCF7L2 · Glycolysis · Tumor immune microenvironment  \nIntroduction  \nPancreatic ductal adenocarcinoma (PDAC) accounts for more than 90% of all pancreatic malignancies, and PDAC patients have a 5-year survival rate of less than 10%[1] .  \nYesiboli Tasiheng, Jiayideng Kenjiabieke and Nuerzhati Tasiheng contributed equally to this work.  \n􀀍 He Cheng [chenghe@fudanpci.org](chenghe@fudanpci.org)  \n1 Department of Surgical Oncology, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China  \n2 Department of Medical Oncology, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi 830000, China  \n3 The People’s Hospital of Jimunai County, Jimunai 836800, China  \nBecause of the difficulty on early diagnosis and rapid progression ability, it’s difficult for patients with pancreatic cancer to undergo effective prevention and radical operation in the early stage [2, 3] . Despite advances in surgical intervention and various therapeutic regimen, the overall  \n4 Department of General Surgery, Xinjiang Medical University, Urumqi 830000, China  \n5 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong An Road, Xu-Hui District, 200032 Shanghai, China  \n6 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China  \n7 Shanghai Pancreatic Cancer Institute, Shanghai 200032, China  \n8 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China  \n1 3  \nprognosis of PDAC remains poor [1] . PDAC is a highly heterogeneous tumor with complex genetic and molecular diversity [4–6] . Although substantial progress has been made in the genetics related to pancreatic cancer, the exact molecular mechanisms still awaited discovery. Identifying the genes involved in tumor progression might lead to more effective treatment strategies to treat this highly malignant tumor.  \nDEP domain-containing 1 (DEPDC1) is a newly identified highly conserved oncogene, encodes protein containing DEP domain [7, 8] . DEPDC1 was undetectable in normal human tissues, with the exception of the testicular surface [7], the highly up-regulated expression leve","cbCaitFh019EYyjG","https://ap.wps.com/l/cbCaitFh019EYyjG","pdf",2565503,12,"English","# Abstract\n# Introduction\n# Materials and methods\n## Bioinformatics methods","[{\"question\":\"What was the main purpose of the study on TCF7L2/DEPDC1 in PDAC?\",\"answer\":\"To determine whether the TCF7L2/DEPDC1 axis contributes to pancreatic cancer progression and to clarify its effects on proliferation, aerobic glycolysis, and immunosuppression.\"},{\"question\":\"How did the researchers assess the relationship between DEPDC1 expression and PDAC prognosis?\",\"answer\":\"They compared DEPDC1 expression in PDAC tissues and adjacent normal tissues and then evaluated how expression levels correlated with patient outcomes.\"},{\"question\":\"What mechanism did the study propose linking TCF7L2 to DEPDC1 and tumor progression?\",\"answer\":\"TCF7L2 up-regulated DEPDC1 by binding specifically to DEPDC1 promoter sequences, which then promoted proliferation and invasion via glycolysis and helped form an immunosuppressive tumor microenvironment.\"}]","TCF7L2/DEPDC1 axis contributes to tumor progression by promoting cell proliferation, aerobic glycolysis, and immunosuppression in pancreatic cancer | PDF",1790107727,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a042915368ce898a220b262b42b73fe.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/868f23f7d70e1bf8e5056e780ea40fb3.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d44f58a5ce6d036edac486ff60b0c5b.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47b797c85f23f856d7722cd61734c19d.webp",980,1301]